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Summary.-C57BL mice were given local irradiation to 2 cm2 of the lower abdomen
in the dose range 16-24 Gy. There were some early deaths, but mice dying between
50-240dayspredominantly developedinvasiveadenocarcinomas oftheintestine. When
the radiosensitizer misonidazole was given in a single dose shortly before irradiation
the proportion of mice developing tumours was higher, but the difference was not
statistically significant. However, there was a significant increase in the incidence of
multiple tumours, largely attributable to tumours arising in the rectum.
CHEMICAL radiosensitizers are now being
extensively investigated because of their
potential ability to reduce the radio-
resistance of tumours. Clinical studies
already under way claim some therapeutic
advantage (Urtasun et al., 1976; Dische
et al., 1977). The usefulness of radiosen-
sitizers will be limited not only by their
acute toxicity but by the possibility that
normal tissues may be "sensitized" to the
carcinogenic effects of the radiation used
for treatment. As part of a study of the
combined effect ofmisonidazole and radia-
tion on normal tissues of the mouse we
have observed carcinomas ofthe small and
large intestines. The present paper is a
report of our initial findings.
MATERIALS AND METHODS
Male C57BL mice were used, 11-13 weeks
of age and weighing 23-27 g, supplied by the
Institute of Cancer Research breeding sta-
tion. For irradiation, the mice were anaesthe-
tized with sodium pentabarbitone, given
i.p. 10-15 min beforehand. Misonidazole
(Ro-07-0582) was given i.p. 45 min before
irradiation at a dose of 1 mg g. Since misoni-
dazole greatly increases the sleeping time
with nembutal anaesthesia, the dose of
anaesthetic was reduced from its normal
value of 60 mg/kg to 40 mg/kg for sensitized
mice.
The irradiation was given locally to a
2 cm2 area ofthe abdomen. Groups of 10 mice
were placed face upwards within a circular
chamber each being located by means of 2
perspex pegs, one on either side of the neck
and bythick pads ofexpanded polystyrene on
either side of the abdomen. The top of the
chamber carried a sheet of 3 mm lead, out
of which a rectangular field had been cut
above each mouse. The field was 1 cm deep
in the sagittal direction and 2 cm wide. It was
positioned centrally over the mouse so as to
miss the lower pole of the kidneys by about
2 mm. Radiographs taken with the 230 kV
therapy X-ray set that was used for the irra-
diations were used to check that the shield
gave accurate positioning of the radiation
fields. Careful dissection ofexternally-marked
miceshowedthatthisfieldalwaysincludedthe
majority of the rectum, the lower colon and
part of the small intestine. The caecum was
notalwaysincludedonaccountofthemobility
of the intestine.
During irradiation the chamber was kept
warm on a heating plate and air at 32°C was
passed through it at a rate of 1 6 1/min. The
radiation quality was 230 kV, 15 mA, with
1 mm Cu and 1 mm Al filtration. Dose rate
was calibrated with a Baldwin-Farmer dose-
meter; the whole of the ionization chamber
was exposed through a lead shield which,
though slightly larger than the 2 cm2 irradia-
tion field, effectively cut out scattered radia-
tion.
Two experiments were performed, each
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TABLE I.--Incidence ofintestinal cancers in mice exposed to irradiation alone
Mice dying between 50 and 240 days*
Radiation
dose Experi-
(Gy) ment
16 II
19 I
20 I
20 II
21 I
22 I
24 I
24 II
Total
Initial
no. mice
22
10
10
22
5
5
10
21
105
Deaths
before
50 days
0
0
1
9
3
2
4
5
24
Total
22
10
9
13
2
3
6
16
81
Number and
(%) with
cancer
4 (18)
7 (70)
6 (67)
10 (77)
1 (50)
2 (67)
5 (83)
14 (88)
49 (60)
Number
with 2
or more
primaries
0
0
2
5
0
0
3
5
15
Total
cancers
4
7
8
15
1
2
8
26
71
Cancers
per
mouse
1*0
1*0
1 3
1-5
1.0
1*O
1 6
1-9
1 -45
* Survivors to 240 days were killed.
TABLE II.Incidence ofintestinal cancers in mice exposed to irradiation plus misonidazole
Mice dying between 50 and 240 days*
Number
Radiation Deaths Number and with 2 Cancers
dose Experi- Initial before (%) with or more Total per
(Gy) ment no. mice 50 days Total cancer primaries cancers mouse
16 II 25 0 25 5 (20) 2 8 1- 6
19 I 5 0 5 4 (80) 1 6 1-5
20 I 5 2 3 3(100) 1 4 1-3
20 II 23 7 16 15 (94) 11 29 1-9
21 I 10 3 7 6 (86) 3 12 2 0
22 I 5 1 4 4(100) 3 7 1-8
24 I 10 2 8 6 (75) 5 11 1-8
24 II 23 10 13 12 (92) 7 21 1- 8
Total 106 25 81 55 (68) 33 98 1- 78
* Survivors to 240 days were killed.
including sensitized and unsensitized mice,
separated in starting time by 6 months.
Experiment I (Tables I and II) was designed
to record late normal-tissue damage following
local irradiation, and detailed post-mortem
examinations were only begun at 100 days
after irradiation. Subsequently, and through-
out Experiment II (Tables I and II) a com-
plete autopsy was done on each mouse
showing signs of distress, or on the termina-
tion of the experiments at 240 days, and
the entire bowel was carefully examined.
The location and extent ofintestinal tumours
was noted and the involved segment, together
with adjacent tissue includingf regional lymph
nodes, was removed for histological examina-
tion. The colon and rectum were removed and
examined histologically. Enlarged lymph
nodes were submitted for histological section-
ing and the lungsand liver carefully examined
for metastases. The tissues were fixed in
buffered formalin, embedded in paraffin and
stained with haematoxylin and eosin. Mucin
stains were used where indicated.
RESULTS
Grossfindings
The mice generally remained healthy
until a few days to I week before death,
when signs of abdominal distension due to
obstruction, ascites or intestinal fistula
were noted. A typical intestinal lesion, as
found at autopsy, is shown in Fig. 1. This
consisted grossly of a lobulated, mucinous
to gelatinous tumour mass which could
be seen invading the serosal surface of the
bowel and the adjacent mesentery. Most of
the colorectal carcinomas were located
beneath the white zone of depigmentation
of the abdominal fur and none arose in a
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FIG. 1.-Gross appearance of an adenocarcinoma in the rectosigmoid area (arrow) in an irradiated
mouse pretreated with misonidazole. The tumour invades the full thickness of the bowel wall and
appears as a multilobulated mucinous mass. N.B. the tumour is located in the irradiated zone, as
indicated by the band of depigmentation.
region of gut that could not, by mobility
of the intestine, have been in the radia-
tion field at the time of exposure.
Two gross types ofcarcinoma were seen;
a constricting annular type typically
found in the descending colon and rectum,
and abulkyfungating tumourmoretypical
ofthe caecum. Polyps were not present in
association with these tumours. Adeno-
carcinomas of the rectum, small intestine,
caecum and colon were usually in regions
of radiation damage, recognized by chro-
nic ulcer, radiation fibrosis, and/or damage
to muscle and blood vessels. Fistulous
communication with adjacent bowel
loops was common, and often presented
as palpable masses.
Microscopicfindings
On microscopic examination, broad
zones of adenocarcinomatous glands could
be seen extending from their origin in the
mucosal surface, through the submucosa
and muscular layers on to the serosal
surface (Fig. 2). A diagnosis of carcinoma
was not made unless there was invasion
through the full thickness of the bowel
wall. When the cancer was in the colo-
rectum, the perirectal fat was invaded and
dilated entrapped seminal vesicles were
often adherent to the bowel.
Histologically, in most cases the adeno-
carcinomas were mucin-secreting. Large
mucin lakes were formed in the external
muscular layer, and these merged on the
peritoneal surface to form the character-
istic lobulated masses shown in Fig. 1.
Only one carcinoma was undifferentiated.
No metastases, either to local lymph nodes
or to distant organs, could be identified.
Tumour incidence
The incidence of tumours in groups of
mice receiving different doses of radiation
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FIG. 2.-Adenocarcinoma of the caecum, showing penetration of carcinomatous glands through
the thickened muscularis to form mucin-secreting and adenomatous masses in the mesentery.
Mouse received 19 Gy plus misonidazole and lived 240 days. H. and E. x 8.
is set out in Tables I and II. Of the 105
mice given irradiation alone, 81 survived
50 days or longer, and at autopsy 60%
of these had adenocarcinomas of the large
and small bowel. In those groups pre-
treated with misonidazole, 81/106 sur-
vived 50 days or longer, and 68% of these
had bowel cancers. In the groups treated
at the lowest radiation dose (16 Gy) the
proportion of mice with tumours was low:
18% without, and 20% with misonidazole.
Among the higher radiation doses, there
was no clear dose-dependence in the inci-
dence of mice with tumours, with or with-
out the radiosensitizer.
Although the difference between the
control and misonidazole groups in the
proportion of mice developing cancer was
not large, the incidence of multiple bowel
tumours was considerably higher in the
sensitized group (41%) than with radia-
tion alone (18%; difference significant at
P<001). The average number of tumours
per mouse was higher in the misonidazole
groups at every radiation level, and in
each of the 2 experiments, the averages
being 1 78 and 1-45 (total cancers divided
by total mice with cancer). The difference
between the misonidazole and control
groups may be most marked in the middle
of the dose range, averaging the results
for a 20 Gy dose shows that the propor-
tion ofmice with cancer was 95% and 73%
respectively (significantly different, P<
0.05) and the proportions of multiple
tumours were 63% and 32% of tumour-
bearing animals (difference significant at
P=0.05).
Comparison of tumour distribution.
A difference was noted in the anatomical
distribution of the tumours induced with
and without misonidazole (Table III).
With radiation alone the commonest site
was the caecum (49% of tumours) with
27% in the rectum. Treatment with
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FiG. 3. Adenocarcinoma of the ileum. Typical appearance, showing neoplastic glands which form
multilobulated masses on the serosal surface. The distended mucin-filled spaces contain des-
quamated tumour cells and macrophages. These lie adjacent to non-mucin-secreting glands of
misonidazole and lived 240 days. H. and E. x 20.
TABLE III.-Distribution ofadenocarcinornas in intestine ofi?radiated mice
Number and (%) of tumours in each site
Misoni- Total Total , -__
dazole animals cancers Rectum Colon Caecum Ileum
Absent 49 71 19 (27) 6 (8) 35 (49) 11 (15)
Present 55 98 39 (40) 8 (8) 36 (37) 15 (15)
misonidazole may have reduced the inci-
dence of caecal tumours, but it seems to
have increased the incidence in the rectum.
This increase in rectal tumours to 40% of
the tumours observed is on the borderline
of significance (P 0.07). Tumours of the
colon and small intestine were similar in
both treatment groups.
DISCUSSION
The present study has shown that
abdominal irradiation of mice pretreated
with the radiosensitizer, misonidazole, led
to a higher incidence ofintestinal tumours
than was observed with radiation alone.
The proportion ofmice developingtumours
was the same in the 2 groups, but the
number of tumours per mouse was greater
in the misonidazole groups; and this was
due to a preferential increase in the
number of tumours in the rectum.
Spontaneous carcinomas of the large
bowel are rare in mice. Wells et al. (1938)
found only 19 in 42,000 mice, 11 of which
arose in association with rectal prolapse.
Only one of the 19 was a caecal adenocar-
cinoma. Dunn (1965) stated that sponta-
neous carcinomas of the large intestine in
mice were always ileocaecal and mucin sec-
reting. The preferential origin of radiation-
induced adenocarcinoma in the caecum
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was brought out in the study of Nowell
et al. (1956) in which whole-body irradia-
tion of mice produced a 27% incidence of
intestinal tumours of both the small and
large bowels. All the neoplasms arising in
the large intestine were in the caecum, and
were mucin-secreting. The technique of
delivering high doses of radiation to isola-
ted segments (Osborne et al., 1963) or well
defined regions ofthe abdomen (Tsubouchi
& Matsuzawa, 1973) has, so far as we are
aware, not previously been used to study
carcinogenesis in the large bowel of the
mouse. We therefore have no comparative
information regarding the origin or distri-
bution ofthese tumours in different mouse
strains or after exposure to varying
amounts ofradiation. However, it appears
from the data of the present experiments
that radiation-induced carcinomas re-
semble the rare spontaneous tumours, in
that they were mostly caecal and mucin-
secreting.
Studies describing intestinal carcino-
genesis with 1-2 dimethyl hydrazine
(DMH) in mice of various strains (Evans
et al., 1972; Haase et al., 1973; Thurnherr
et al., 1973) have consistently demon-
strated a preponderance of tumours, often
polyploid, in the distal half of the colon
and in the rectum. A similar tumour dis-
tribution has been found in rats injected
withDMH (Rogersetat., 1973; Reddyetal.,
1976) and in rats treated with methyl-
azoxymethanol (Reuber, 1976; Zedeck &
Sternberg, 1974). Caecal tumours are
rarely found in animals receiving these
chemicals.
In our experiments, the proportion of
mice developing caecal carcinomas was
higher (50%) in the control than (37%)
in the sensitized group. This may have
been due to some mice dying of rectal
tumours before they had time to develop
caecal lesions. The incidence of ileal and
colonic carcinomas was similar, whilst the
incidence ofrectal carcinomas with misoni-
dazole was higher (4000) than in the
irradiated group (2700).
The fact that our data (Tables I and II)
show a significant increase in multiple
tumours, but only a slight and statistically
non-significant increase in the proportion
of mice with tumours is puzzling. Both
measures of response were, however,
higher in the misonidazole groups, and we
are inclined to attribute this discrepancy
to chance.
Rustia and Shubik (1972) tested the car-
cinogenicity of the related compound 5-
metronidazole (Flagyl) in Swiss mice by
oral administration. They found the
incidence of lung adenomas was increased
at all dose levels, from 0.06% to 0 5% of
diet. Increased incidence of malignant
lymphoma was found in mice receiving
0 3-0 5%O of their diet as Flagyl. Several
mice developed squamous papillomas of
the forestomach, one a squamous cell car-
cinoma and a second an adenocarcinoma
of the stomach, but none developed small
or large bowel tumours. The failure of
these mice to develop bowel tumours,
despite the presence of Flagyl in the diet
over their entire life-span, does not support
the supposition that Flagyl is itself a
carcinogen for mouse intestine. We are not
aware ofany studies onthe carcinogenicity
of misonidazole in mouse intestine.
The possibility that misonidazole may
sensitize normal intestinal cells to the
carcinogenic effect of radiation appears to
be a more appropriate explanation for the
results of the present experiments. The
magnitude of the effect that we have seen
is not large, and in our view it does not
seriously call into question the present
clinical use of chemical radiosensitizers.
Our results may however, serve as a
warning that these agents could enhance
the incidence of second cancers in patients
who achieve long-term control of malig-
nancy.
We gratefully acknowledge the help of Mr Ted
Merryweather in care of the animals and Sue Clinton
for preparation of histological slides.
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